Orthofix Medical (OFIX) Stock Price

Orthofix Medical Price

NASDAQ·CLOSED
10.59USD+0.24 (+2.24 %)
Market closed

Revenue has compounded at 4.4% per year over the past 19 years to 822.31 M USD. Earnings per share have declined at 11.6% per year over the last 13 years. Orthofix Medical's net margin stands at -11.2%, down from -8.3% several years earlier. Analysts set a median price target of 20.40 USD, implying 92.6% above the current price. Of 12 analysts, 9 rate the stock a buy — an overall Buy consensus. The stock trades about 16% above its 52-week low.

Orthofix Medical stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Orthofix Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Orthofix Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Orthofix Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Orthofix Medical Stock Price History
DateOrthofix Medical Price
8/19/202610.59 USD
8/18/202610.35 USD
8/14/202610.34 USD
8/13/202610.18 USD
8/12/202610.40 USD
8/11/202610.32 USD
8/10/202610.26 USD
8/7/202610.28 USD
8/6/202610.60 USD
8/5/202610.60 USD
8/4/202612.17 USD
8/3/202612.26 USD
7/31/202611.80 USD
7/30/202611.79 USD
7/29/202611.99 USD
7/27/202611.73 USD
7/23/202610.96 USD
7/22/202611.02 USD
7/21/202611.63 USD
7/20/202611.56 USD
7/17/202611.58 USD
7/16/202611.89 USD
7/15/202611.29 USD
7/14/202610.95 USD
7/13/202611.92 USD
7/10/202611.63 USD
7/9/202611.48 USD
7/8/202611.58 USD
7/7/202611.72 USD
7/6/202611.07 USD
7/2/20269.94 USD
7/1/20269.35 USD
6/30/20269.14 USD
6/29/20269.68 USD
6/26/20269.78 USD
6/25/20269.31 USD
6/24/20269.36 USD
6/23/20269.10 USD
6/22/20269.36 USD
6/18/20269.20 USD
6/17/20269.65 USD
6/16/20269.40 USD
6/15/20269.30 USD
6/12/20269.24 USD
6/11/20269.47 USD
6/10/20269.95 USD
6/9/20269.87 USD
6/8/20269.69 USD
6/5/202610.46 USD
6/4/202610.26 USD
6/3/20269.55 USD
6/2/20269.59 USD
6/1/20269.35 USD
5/29/20269.35 USD
5/28/20269.53 USD
5/27/20269.22 USD
5/26/20269.60 USD
5/22/202610.76 USD
5/21/202610.45 USD
5/20/202612.08 USD
5/19/202612.09 USD
5/18/202612.14 USD
5/15/202612.01 USD
5/14/202612.29 USD
5/13/202612.21 USD
5/12/202612.18 USD
5/11/202611.67 USD
5/8/202611.65 USD
5/7/202612.07 USD
5/6/202612.19 USD
5/5/202612.44 USD
5/4/202612.01 USD
5/1/202611.91 USD
4/30/202611.76 USD
4/29/202611.49 USD
4/28/202611.91 USD
4/27/202612.32 USD
4/24/202612.35 USD
4/23/202612.15 USD
4/22/202612.14 USD
4/21/202612.10 USD
4/20/202612.65 USD
4/17/202612.71 USD
4/16/202612.39 USD
4/15/202612.87 USD
4/14/202612.72 USD
4/13/202612.65 USD
4/10/202612.38 USD
4/9/202612.42 USD
4/8/202612.20 USD
4/7/202611.71 USD
4/6/202611.77 USD
4/2/202611.53 USD
4/1/202611.61 USD
3/31/202611.47 USD
3/30/202611.32 USD
3/27/202611.50 USD
3/26/202611.79 USD
3/25/202611.93 USD
3/24/202611.72 USD
3/23/202611.87 USD
3/20/202611.65 USD
3/19/202611.70 USD
3/18/202611.70 USD
3/17/202612.03 USD
3/16/202611.87 USD
3/13/202611.70 USD
3/12/202612.03 USD
3/11/202612.27 USD
3/10/202612.37 USD
3/9/202612.46 USD
3/6/202612.62 USD
3/5/202612.57 USD
3/4/202612.87 USD
3/3/202613.03 USD
3/2/202613.37 USD
2/27/202613.53 USD
2/26/202613.17 USD
2/25/202613.04 USD
2/24/202612.75 USD
2/23/202613.59 USD
2/20/202613.87 USD
2/19/202613.77 USD
2/18/202613.76 USD
2/17/202613.50 USD
2/13/202613.38 USD
2/12/202613.27 USD
2/11/202613.50 USD
2/10/202613.37 USD
2/9/202613.06 USD
2/6/202612.80 USD
2/5/202612.70 USD
2/4/202612.85 USD
2/3/202613.03 USD
2/2/202613.45 USD
1/30/202613.23 USD
1/29/202613.13 USD
1/28/202613.14 USD
1/27/202613.33 USD
1/26/202613.24 USD
1/23/202613.33 USD
1/22/202613.83 USD
1/21/202613.85 USD
1/20/202613.64 USD
1/16/202614.05 USD
1/15/202614.40 USD
1/14/202614.32 USD
1/13/202614.81 USD
1/12/202615.25 USD
1/9/202615.78 USD
1/8/202616.20 USD
1/7/202615.73 USD
1/6/202615.60 USD
1/5/202615.33 USD
1/2/202614.84 USD
12/31/202515.16 USD
12/30/202515.33 USD
12/29/202515.48 USD
12/26/202515.24 USD
12/24/202515.16 USD
12/23/202514.99 USD
12/22/202515.49 USD
12/19/202515.46 USD
12/18/202515.56 USD
12/17/202515.47 USD
12/16/202515.55 USD
12/15/202515.71 USD
12/12/202515.49 USD
12/11/202515.71 USD
12/10/202515.83 USD
12/9/202515.67 USD
12/8/202515.63 USD
12/5/202515.90 USD
12/4/202515.90 USD
12/3/202515.92 USD
12/2/202515.72 USD
12/1/202515.86 USD
11/28/202516.09 USD
11/26/202516.14 USD
11/25/202516.13 USD
11/24/202515.81 USD
11/21/202515.26 USD
11/20/202514.29 USD
11/19/202514.46 USD
11/18/202514.40 USD
11/17/202514.40 USD
11/14/202514.95 USD
11/13/202515.01 USD
11/12/202515.30 USD
11/11/202515.38 USD
11/10/202515.03 USD
11/7/202514.96 USD
11/6/202514.68 USD
11/5/202514.97 USD
11/4/202514.87 USD
11/3/202516.06 USD
10/31/202515.44 USD
10/30/202515.47 USD
10/29/202515.32 USD
10/28/202516.02 USD
10/27/202516.08 USD
10/24/202515.90 USD
10/23/202515.92 USD
10/22/202516.23 USD
10/21/202515.72 USD
10/20/202515.62 USD
10/17/202515.26 USD
10/16/202515.25 USD
10/15/202515.04 USD
10/14/202514.79 USD
10/13/202514.50 USD
10/10/202514.20 USD
10/9/202514.02 USD
10/8/202514.37 USD
10/7/202514.20 USD
10/6/202514.17 USD
10/3/202514.45 USD
10/2/202514.21 USD
10/1/202514.34 USD
9/30/202514.64 USD
9/29/202514.36 USD
9/28/202514.36 USD
9/25/202514.29 USD
9/24/202514.38 USD
9/23/202514.75 USD
9/22/202514.86 USD
9/19/202514.72 USD
9/18/202515.48 USD
9/17/202514.94 USD
9/16/202514.84 USD
9/15/202514.75 USD
9/12/202514.92 USD
9/11/202515.00 USD
9/10/202514.25 USD
9/9/202514.61 USD
9/8/202514.70 USD
9/5/202514.56 USD
9/4/202514.70 USD
9/3/202514.75 USD
9/2/202514.89 USD
8/29/202514.88 USD
8/28/202514.74 USD
8/27/202514.84 USD
8/26/202514.51 USD
8/25/202514.50 USD
8/22/202514.59 USD
8/21/202514.55 USD
8/20/202514.53 USD
Access this data via the Eulerpool API
Get Free API Key

Orthofix Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
746.64 M USD
-140.05 M USD
-151.40 M USD
Jan 1, 2024
799.49 M USD
-84.62 M USD
-126.00 M USD
Jan 1, 2025
822.31 M USD
-73.32 M USD
-92.19 M USD
Jan 1, 2026 (e)
850.96 M USD
-76.80 M USD
16.24 M USD
Jan 1, 2027 (e)
871.91 M USD
-80.66 M USD
14.65 M USD
Jan 1, 2028 (e)
936.57 M USD
-85.29 M USD
-13.27 M USD
Jan 1, 2029 (e)
1.00 B USD
-91.43 M USD
0.00 USD
Jan 1, 2030 (e)
1.06 B USD
-96.26 M USD
0.00 USD

Orthofix Medical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 20, 2026, 11:29 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
0.400.410.430.450.460.410.460.460.750.800.820.850.870.941.001.06
-1.493.285.874.621.32-11.5514.29-0.8662.177.102.883.412.477.467.265.28
78.0378.4878.5278.5978.2174.8875.2273.2665.1568.2167.0367.0367.0367.0367.0367.03
309.00321.00340.00356.00359.00304.00349.00337.00486.00545.00551.00569.77583.85627.42673.00708.52
9.0021.0040.0030.00-26.00-6.00-8.00-16.00-140.00-84.00-73.00-76.00-80.00-85.00-91.00-96.00
2.275.139.246.62-5.66-1.48-1.72-3.48-18.77-10.51-8.88-8.94-9.18-9.08-9.06-9.08
-2.003.006.0013.00-28.002.00-38.00-19.00-151.00-125.00-92.0016.0014.00-13.00––
-75.00-250.00100.00116.67-315.38-107.14-2,000.00-50.00694.74-17.22-26.40-117.39-12.50-192.86––
19.0617.8618.7719.0519.3219.4019.8620.2037.2438.7040.0040.0040.0040.0040.0040.00
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Orthofix Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Orthofix Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Orthofix Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Orthofix Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Orthofix Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Orthofix Medical stock margins

The Orthofix Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Orthofix Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Orthofix Medical.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
75.26 %
-1.79 %
-8.26 %
Jan 1, 2022
73.18 %
-3.56 %
-4.29 %
Jan 1, 2023
65.13 %
-18.76 %
-20.28 %
Jan 1, 2024
68.28 %
-10.58 %
-15.76 %
Jan 1, 2025
67.09 %
-8.92 %
-11.21 %
Jan 1, 2026 (e)
67.09 %
-9.03 %
1.91 %
Jan 1, 2027 (e)
67.09 %
-9.25 %
1.68 %
Jan 1, 2028 (e)
67.09 %
-9.11 %
-1.42 %

Orthofix Medical Stock Revenue, EBIT, Earnings per Share

The Orthofix Medical earnings per share therefore indicates how much revenue Orthofix Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
23.39 USD
-0.42 USD
-1.93 USD
Jan 1, 2022
22.81 USD
-0.81 USD
-0.98 USD
Jan 1, 2023
20.05 USD
-3.76 USD
-4.07 USD
Jan 1, 2024
20.66 USD
-2.19 USD
-3.26 USD
Jan 1, 2025
20.56 USD
-1.83 USD
-2.30 USD
Jan 1, 2026 (e)
21.49 USD
-1.92 USD
0.41 USD
Jan 1, 2027 (e)
22.02 USD
-2.02 USD
0.37 USD
Jan 1, 2028 (e)
23.65 USD
-2.13 USD
-0.34 USD

Orthofix Medical business model & stock analysis

Orthofix Medical Inc is a leading global company in the field of orthopedic medical devices. The company is headquartered in Lewisville, Texas, USA and has been publicly traded since 1987. Orthofix's history dates back to the 1970s when it was founded as a small startup company. Since then, it has grown into a multinational company employing several thousand employees worldwide. Orthofix's business model is based on developing, manufacturing, and distributing orthopedic products and services that contribute to the restoration of mobility and quality of life for people with orthopedic conditions and injuries. The company offers a wide range of products ranging from implantable medical devices to conservative therapy options. Orthofix operates in three main divisions: 1. Spinal Implants and Biologics: This includes products such as intervertebral disc implants, interactive spinal fracture systems, and biological products to support bone healing. 2. Extremity Fixation: In this area, the company offers various implants for stabilizing fractures and joints, such as wrist supports or nail implants for stabilizing bone fractures in the arms and legs. 3. Orthofix PhysioStim: Orthofix PhysioStim is a non-invasive therapy option that supports bone and soft tissue healing. It is a portable device that generates electrical impulses and is used over an extended period of time. Orthofix's broad product portfolio also includes specialized products and services tailored to specific medical needs and groups. For example, the company offers some products specifically for children, such as the Pediatric Locking Nail System, a nail system for treating forearm and leg fractures in children. The company also provides products for animals, such as the VetLok External Fixation System, an implant system for stabilizing bone fractures in animals. Orthofix is committed to quality and product innovation to meet the needs of its customers and differentiate itself in a highly competitive market. The company continuously invests in research and development to develop new technologies and products that contribute to improving patient outcomes and support the work of doctors and surgeons. Overall, Orthofix Medical Inc is a leading company in the field of orthopedic medical devices, offering a wide range of products and services to support patients in restoring their mobility and quality of life. The company is committed to quality, innovation, and customer satisfaction, and invests in research and development to play a leading role in a competitive market.

Orthofix Medical SWOT Analysis

Strengths

Orthofix Medical Inc. has several strengths that contribute to its competitive advantage in the market.

  • Diverse product portfolio: Orthofix offers a wide range of innovative medical devices and solutions, catering to different orthopedic needs and specialties.
  • Established brand: With years of experience and a strong reputation, Orthofix has built trust among healthcare professionals and patients alike.
  • Global presence: The company operates in multiple countries, allowing it to reach a larger customer base and tap into international markets.
  • Strong research and development capabilities: Orthofix invests heavily in R&D, enabling it to introduce cutting-edge technologies and stay ahead of competitors.

Weaknesses

Despite its strengths, Orthofix Medical Inc. also faces certain weaknesses that may hinder its growth and performance.

  • Dependence on specific markets: Orthofix is heavily reliant on the orthopedic market, making it vulnerable to fluctuations in this specific industry.
  • Regulatory challenges: Due to the nature of the medical device industry, Orthofix is subject to stringent regulations and compliance requirements, which can impede product development and approval timelines.
  • Limited diversification: The company's product range, although diverse within the orthopedic sector, may limit its ability to explore other potential markets for growth.

Opportunities

Orthofix Medical Inc. can capitalize on various opportunities to further expand its presence and improve its market position.

  • Emerging markets: The growing demand for orthopedic devices in developing economies presents significant opportunities for Orthofix to expand its customer base and increase sales.
  • Advancements in technology: Technological advancements and innovations in the medical field can open new possibilities for Orthofix to develop and introduce more advanced and effective products.
  • Increasing geriatric population: As the global population continues to age, there is a higher prevalence of orthopedic conditions, creating a larger market for Orthofix's solutions.

Threats

Orthofix Medical Inc. should be mindful of potential threats that may impact its operations and market position.

  • Intense competition: The orthopedic industry is highly competitive, with numerous players vying for market share. Orthofix needs to continuously innovate and differentiate its offerings to stay ahead.
  • Economic downturns: During economic downturns, healthcare spending may decrease, affecting the demand for orthopedic devices and potentially squeezing Orthofix's revenues.
  • Changing regulatory landscape: Regulatory changes can disrupt product development, approval processes, and operations, requiring Orthofix to adapt quickly to ensure compliance.

Orthofix Medical Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Orthofix Medical Employees
Details
Date
Orthofix Medical Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Orthofix Medical Segments

Orthofix Medical Revenue by Segment (1/6)

  • Max

M6-C Artificial Cervical Disc
M6-L Artificial Lumbar Disc
Details
Date
M6-C Artificial Cervical Disc
M6-L Artificial Lumbar Disc
Jan 1, 2017
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
Jan 1, 2024
23.40 M USD
23.40 M USD
Jan 1, 2025
0.00 USD
0.00 USD

Orthofix Medical Revenue by Segment (2/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Details
Date
Strategic Products
Spine Products
Orthopedics Products
Stimulation Products
Implants and Biologics Products
Sports Medicine Products
Divested Products
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Orthofix Medical Revenue by Segment (3/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Global spine
Bone Growth Therapies
BioStim
Global Orthopedics
Orthofix Extremities
Extremity fixation
Global extremities
Spine fixation
Biologics
Details
Date
Global spine
Spine Reporting Segment
Bone Growth Therapies
BioStim
Orthopedics Reporting Segment
Global Orthopedics
Sports Medicine Reporting Segment
Orthofix Extremities
Extremity fixation
Global extremities
Spine fixation
Biologics
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
185.90 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
103.24 M USD
0.00 USD
81.96 M USD
62.72 M USD
Jan 1, 2018
0.00 USD
0.00 USD
195.25 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
106.45 M USD
0.00 USD
0.00 USD
0.00 USD
59.68 M USD
Jan 1, 2019
357.22 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
102.73 M USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
55.48 M USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
56.42 M USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
56.38 M USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
124.18 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Orthofix Medical Revenue by Segment (4/6)

  • 3 Years

  • 5 Years

  • Max

Global Spine
Global Orthopedics
Spinal Implants
Global extremities
Details
Date
Global Spine
Global Orthopedics
Spinal Implants
Global extremities
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
91.66 M USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
94.54 M USD
0.00 USD
Jan 1, 2020
321.74 M USD
0.00 USD
0.00 USD
84.83 M USD
Jan 1, 2021
358.96 M USD
105.52 M USD
0.00 USD
0.00 USD
Jan 1, 2022
353.17 M USD
107.54 M USD
0.00 USD
0.00 USD
Jan 1, 2024
675.31 M USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
687.66 M USD
0.00 USD
0.00 USD
0.00 USD

Orthofix Medical Revenue by Segment (5/6)

  • 3 Years

  • 5 Years

  • Max

Bone Growth Therapies
Global Limb Reconstruction
Spinal Implants
Biologics
Details
Date
Bone Growth Therapies
Global Limb Reconstruction
Spinal Implants
Biologics
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
65.50 M USD
Jan 1, 2020
171.40 M USD
0.00 USD
94.86 M USD
0.00 USD
Jan 1, 2021
187.45 M USD
0.00 USD
115.09 M USD
0.00 USD
Jan 1, 2022
187.25 M USD
0.00 USD
109.55 M USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
134.66 M USD
0.00 USD
0.00 USD

Orthofix Medical Revenue by Segment (6/6)

  • 3 Years

  • 5 Years

  • Max

Bone Growth Therapies
Details
Date
Bone Growth Therapies
Jan 1, 2017
0.00 USD
Jan 1, 2018
0.00 USD
Jan 1, 2019
197.18 M USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD

Orthofix Medical Revenue by Region

  • 3 Years

  • 5 Years

  • Max

United States
International
Others
Customers and Distributors Based in Europe
Represents the geographic areas not specifically disclosed
Italy
United Kingdom
France
Germany
Brazil
Details
Date
United States
International
Others
Customers and Distributors Based in Europe
Represents the geographic areas not specifically disclosed
Italy
United Kingdom
France
Germany
Brazil
Jan 1, 2017
345.15 M USD
0.00 USD
0.00 USD
57.00 M USD
52.54 M USD
17.06 M USD
8.73 M USD
0.00 USD
0.00 USD
10.36 M USD
Jan 1, 2018
355.35 M USD
97.69 M USD
0.00 USD
69.00 M USD
50.90 M USD
19.33 M USD
8.73 M USD
0.00 USD
11.61 M USD
7.12 M USD
Jan 1, 2019
361.94 M USD
98.02 M USD
0.00 USD
69.00 M USD
47.99 M USD
19.56 M USD
10.09 M USD
0.00 USD
12.69 M USD
7.69 M USD
Jan 1, 2020
327.28 M USD
79.28 M USD
0.00 USD
57.70 M USD
39.12 M USD
18.73 M USD
7.15 M USD
0.00 USD
11.94 M USD
2.35 M USD
Jan 1, 2021
361.95 M USD
102.53 M USD
0.00 USD
0.00 USD
42.50 M USD
20.19 M USD
10.55 M USD
10.48 M USD
13.72 M USD
5.11 M USD
Jan 1, 2022
358.84 M USD
101.87 M USD
44.99 M USD
0.00 USD
0.00 USD
19.10 M USD
10.17 M USD
10.38 M USD
11.57 M USD
5.67 M USD
Jan 1, 2024
672.82 M USD
126.68 M USD
66.40 M USD
0.00 USD
0.00 USD
21.00 M USD
11.18 M USD
13.39 M USD
9.00 M USD
5.71 M USD
Jan 1, 2025
684.07 M USD
138.25 M USD
76.73 M USD
0.00 USD
0.00 USD
22.28 M USD
13.33 M USD
11.96 M USD
9.11 M USD
4.84 M USD

Orthofix Medical Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Orthofix Medical historical P/E ratio, EBIT multiple, and P/S ratio

Orthofix Medical annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Orthofix Medical shares outstanding

The number of shares of Orthofix Medical was 40 M in 2025. This indicates how many shares Orthofix Medical is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
19.86 M Stocks
Jan 1, 2022
20.20 M Stocks
Jan 1, 2023
37.24 M Stocks
Jan 1, 2024
38.70 M Stocks
Jan 1, 2025
40.00 M Stocks
Jan 1, 2026 (e)
40.00 M Stocks
Jan 1, 2027 (e)
40.00 M Stocks
Jan 1, 2028 (e)
40.00 M Stocks

Current Orthofix Medical forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
13.04 %
Buy
75.00 % (9)
Hold
25.00 % (3)
Sell
0.00 % (0)
12M Price Target
20.40
Last Price
10.59
Currency
USD
12M Return Potential
92.63 %
LTM Return
0 %

Orthofix Medical Analyst Rating Actions

DateFirmActionRatingReliability
8/10/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy65
7/6/2026
Barrington Research
Barrington Research
MaintainedOutperform63
5/22/2026
Stifel
Stifel
MaintainedBuy56
5/22/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy65
5/22/2026
Barrington Research
Barrington Research
MaintainedOutperform63
4/10/2026
Barrington Research
Barrington Research
MaintainedOutperform63
3/9/2026
Stifel
Stifel
MaintainedBuy56
2/26/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy65
2/25/2026
Barrington Research
Barrington Research
MaintainedOutperform63
2/17/2026
Barrington Research
Barrington Research
MaintainedOutperform63

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Orthofix Medical Earnings Calls

2025

Orthofix Medical Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/5/2026-0.42USD-213.46 MUSD-2026 Q2
5/5/2026-0.69USD-197.86 MUSD-2026 Q1
2/24/2026-0.32USD-223.09 MUSD-2025 Q4
11/6/2024-0.08USD-202.93 MUSD-2024 Q3
5/7/2024-0.10USD-190.56 MUSD-2024 Q1
3/4/2024-0.08USD-199.22 MUSD-2023 Q4
8/6/2020-1.10USD-51.50 MUSD-2020 Q2

EESG©

Eulerpool ESG Scorecard© for the Orthofix Medical stock

38/100
30
Environment
33
Social
52
Governance
E

Environment

20
Scope 1 - Direct Emissions669
Scope 2 - Indirect emissions from purchased energy2,619
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions3,288
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees49
Percentage of women in management—
Percentage of Asian employees13
Share of Asian management8
Percentage of Hispanic/Latino employees17
Hispano/Latino Management share8
Percentage of Black employees8
Black Management Share5
Percentage of white employees56
White Management Share73
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Orthofix Medical shareholder structure

% Name
11.55473%
ENGINE CAPITAL MANAGEMENT, LP
ENGINE CAPITAL MANAGEMENT, LP
11.21854%
JUNIPER INVESTMENT COMPANY, LLC
JUNIPER INVESTMENT COMPANY, LLC
9.39827%
RUBRIC CAPITAL MANAGEMENT LP
RUBRIC CAPITAL MANAGEMENT LP
8.40040%
BLACKROCK, INC.
BLACKROCK, INC.
8.33459%
PARADIGM CAPITAL MANAGEMENT INC/NY
PARADIGM CAPITAL MANAGEMENT INC/NY
8.24242%
ARMISTICE CAPITAL, LLC
ARMISTICE CAPITAL, LLC
...

Orthofix Medical Beneficial Ownership Filings (SEC 13D/G)

Free Float
98.9%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
17.20%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
11.00%
Juniper Investment Company, LLC
Juniper Investment Company, LLC
SEC ↗
11.00%
John A. Bartholdson
John A. Bartholdson
SEC ↗
11.00%
Alexis P. Michas
Alexis P. Michas
SEC ↗
10.90%
Engine Capital Management GP, LLC
Engine Capital Management GP, LLC
SEC ↗
10.90%
Ajdler Arnaud
Ajdler Arnaud
SEC ↗
10.79%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
9.97%
David Rosen
David Rosen
SEC ↗
9.90%
Engine Investments, LLC
Engine Investments, LLC
SEC ↗
9.79%
Steven Boyd
Steven Boyd
SEC ↗

Orthofix Medical Executives and Management Board

17 members · avg. age 56 · 24 % women

MC

Mr. Massimo Calafiore (53)

President, Chief Executive Officer, Director · since 2024

10.63 M USD

Management

LV

Mr. Lucas Vitale (49)

Chief People and Business Operations Officer

4.13 M USD
JA

Ms. Julie Andrews (54)

Chief Financial Officer

3.17 M USD
MR

Mr. Max Reinhardt (54)

President - Global Spine

2.78 M USD
JC

Mr. J. Andres Cedron (44)

Chief Legal Officer

2.36 M USD
GG

Mr. Geoffrey Gillespie (52)

Chief Accounting Officer

917,932.00 USD
PF

Mr. Patrick Fisher (51)

President - Global Orthopedics

–

Board of Directors

MF

Mr. Michael Finegan (61)

Independent Chairman of the Board · since 2006

472,320.00 USD
AB

Mr. Alan Bazaar (55)

Independent Director

379,453.00 USD
CK

Mr. Charles Kummeth (64)

Independent Director

375,189.00 USD
JH

Mr. Jason Hannon (53)

Independent Director

296,201.00 USD
MP

Mr. Michael Paolucci (65)

Independent Director

291,918.00 USD
WB

Mr. Wayne Burris (70)

Independent Director

274,289.00 USD

Orthofix Medical Supply Chain

Orthofix Medical Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
2 companies
#NameTrend
1
MTS Systems Corporation
Supplier·US
-0.56
-0.34
0.01
0.42
—
—
2
Ascendis Health
Customer·Oil, Gas & Consumable Fuels·ZA
-0.45
-0.61
-0.34
0.22
-0.22
-0.02

Frequently asked questions about Orthofix Medical

The business model of Orthofix Medical Inc. revolves around providing innovative medical solutions for the orthopedic and spine markets. The company focuses on developing, manufacturing, and marketing advanced medical devices and non-invasive orthopedic solutions. Orthofix Medical Inc. aims to improve patients' quality of life by offering technologically advanced products and therapies that aid in the treatment of various musculoskeletal conditions. They strive to deliver exceptional patient outcomes by combining industry-leading technology, clinical expertise, and evidence-based medicine. Orthofix Medical Inc. is committed to driving innovation, advancing patient care, and solidifying its position as a leading player in the orthopedic medical device industry.

Orthofix Medical Inc is primarily active in the healthcare industry, specifically focusing on orthopedic medical devices. With a strong commitment to improving patient mobility and quality of life, Orthofix offers a wide range of innovative products and solutions in spine fixation, bone growth stimulation, and biologics. Their expertise in orthopedics allows them to serve various healthcare professionals, including surgeons, physicians, and hospitals worldwide. Orthofix Medical Inc's extensive experience and dedication to advancing orthopedic care make them a key player in the industry, providing valuable solutions for patients and healthcare providers alike.

The main competitors of Orthofix Medical Inc in the market include Stryker Corporation, Zimmer Biomet Holdings Inc, DJO Global, Inc, and Medtronic PLC.

Orthofix Medical Inc. is a renowned medical device company with a rich history and background. Established in 1987, Orthofix has been dedicated to advancing orthopedic solutions and improving patient outcomes. With its headquarters in Lewisville, Texas, the company operates through various business segments, including Spinal Implants, Biologics, and External Fixation. Orthofix is committed to delivering innovative and high-quality products that help patients regain mobility and improve their quality of life. The company has a global presence and serves healthcare providers and patients worldwide. With its strong focus on research and development, Orthofix continues to shape the future of orthopedic care.

Orthofix Medical Inc has achieved significant milestones throughout its history. One notable achievement is the company's development of innovative medical devices and solutions for orthopedic and spine conditions. Additionally, Orthofix Medical Inc has successfully expanded its global presence, reaching healthcare professionals and patients worldwide. The company has also demonstrated its commitment to research and development, continuously introducing advanced technologies and treatments in the orthopedic field. Moreover, Orthofix Medical Inc has made strategic acquisitions and partnerships, further enhancing its product portfolio and market position. These milestones showcase Orthofix Medical Inc's dedication to improving patient outcomes and advancing the field of orthopedics.

Orthofix Medical Inc is primarily present in countries and regions worldwide. The company operates in North America, Europe, Asia-Pacific, Latin America, and the Middle East. With a global presence, Orthofix Medical Inc has established a strong market position and serves patients and healthcare professionals in multiple countries and regions.

Orthofix Medical Inc represents the values of innovation, integrity, and patient-centricity. With a corporate philosophy deeply rooted in improving patients' lives, Orthofix Medical Inc is committed to developing and providing innovative orthopedic solutions. The company strives to maintain the highest standards of integrity and ethical conduct in all its operations. Through its cutting-edge technologies and dedication to research and development, Orthofix Medical Inc aims to deliver advanced medical devices and therapies that meet the unique needs of patients worldwide.

Analysts currently set an average price target of 20.71 USD for the Orthofix Medical stock (median: 20.40 USD), implying +95.5 % versus the latest price. The consensus is based on 12 analyst ratings.

Orthofix Medical Analyst Price Targets 2026

12 analysts currently rate the Orthofix Medical stock: 9 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Orthofix Medical to generate revenue of 850.96 M USD and earnings per share of 0.41 USD.

Orthofix Medical Analyst Price Targets 2026

Converted at the current exchange rate, the Orthofix Medical share trades at 9.09 EUR (10.59 USD).

The Orthofix Medical share (OFIX) is listed on 2 stock exchanges, including: NASDAQ (OFIX), Frankfurt (OM2.F).

Orthofix Medical Inc is a globally leading medical technology company specializing in innovative orthopedic products in the global market. The company is headquartered in Lewisville, Texas, and has offices in over 50 countries. Orthofix Medical Inc specializes in providing high-quality solutions for complex orthopedic problems. Orthofix Medical consists of four main business areas: Extremities, Spine, Biologics, and International Operations. The Extremities division focuses on manufacturing products and instruments that target wrist and elbow surgery. The Spine division produces solutions for a variety of back problems, including herniated discs, scoliosis, and other complications. Biologics produces biological products that promote natural body regeneration and are suitable for use in orthopedic surgery. The International division supports the businesses that Orthofix Medical Inc operates in Europe, Asia, Latin America, and other regions of the world. Orthofix Medical Inc offers a wide range of products, including orthopedic implants, surgical instruments, bio-implants, and biological allografts. The company is a leader in developing solutions for bone regeneration and arthroscopic surgery. Among Orthofix Medical Inc's most well-known products are the M6-C core replacement, Octopus leg holder, and Trinity-ELITE bone replacement. In addition to its core competency of manufacturing high-quality orthopedic products, Orthofix Medical also offers innovative services. Orthofix Medical Inc provides its customers with training, certification programs, technical support, and consultation. Supporting physicians and clinics is an important part of Orthofix Medical's business philosophy. The business strategy of Orthofix Medical Inc aims to promote company growth through organic expansion and strategic acquisitions of companies operating in the fields of orthopedics, biology, and surgery. The company continuously invests in research and development to develop innovative solutions to address complex orthopedic challenges. Orthofix Medical Inc is also committed to high social and environmentally-friendly standards. The company follows a proactive environmental policy and strives to utilize resources efficiently and reduce waste. Orthofix Medical's corporate responsibility is also evident in its support of nonprofit organizations and its employees' involvement in supporting social projects. Overall, Orthofix Medical Inc has taken a leading role in the orthopedic industry by offering innovative products and services that help clinics and physicians address complex orthopedic problems. The company is committed to promoting its growth through continuous innovation and a proactive commitment to social and environmental responsibility.

The expected revenue of Orthofix Medical is 850.96 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Orthofix Medical is 16.24 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Orthofix Medical is currently 26.09. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Orthofix Medical stock.

The price-to-sales ratio (P/S) of Orthofix Medical is currently 0.50. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Orthofix Medical stock.

The Eulerpool Quality Score for Orthofix Medical is 3/10.

The ISIN of Orthofix Medical is US68752M1080. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Orthofix Medical is A2NB0X. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Orthofix Medical is OFIX. The ticker symbol is used to trade Orthofix Medical shares on the stock exchange.

Orthofix Medical paid dividends every year for the past 0 years.

Orthofix Medical is assigned to the 'Health' sector.

The dividends of Orthofix Medical are distributed in USD.

All fundamentals and in-depth analysis of Orthofix Medical

Our stock analysis for Orthofix Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orthofix Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Orthofix Medical Stock
Orthofix Medical Revenue→
Orthofix Medical Stock
Orthofix Medical Net Income→
Orthofix Medical Stock
Orthofix Medical P/E→
Orthofix Medical Stock
Orthofix Medical P/S→
Orthofix Medical Stock
Orthofix Medical EBIT→
Orthofix Medical Stock
Orthofix Medical Dividend→
Orthofix Medical Stock
Orthofix Medical Directors Dealings→
Orthofix Medical Stock
Orthofix Medical Stocks→
Orthofix Medical Stock
Orthofix Medical Market capitalization→
Orthofix Medical Stock
Orthofix Medical Debt→
Orthofix Medical Stock
Orthofix Medical Liabilities→
Orthofix Medical Stock
Orthofix Medical Equity→
Orthofix Medical Stock
Orthofix Medical AAQS→
Orthofix Medical Stock
Orthofix Medical Employees→
Orthofix Medical Stock
Orthofix Medical ROE→
Orthofix Medical Stock
Orthofix Medical ROA→
Orthofix Medical Stock
Orthofix Medical ROCE→
Orthofix Medical Stock
Orthofix Medical News→
Orthofix Medical Stock
Orthofix Medical Analyst Price Targets→

Health Stocks

OrthometrixOrthocellOrthoPediatricsOrion OyjOrtin GlobalOriola OyjOrtivusOrient Pharma CoOruka TherapeuticsOrient Europharma CoOryzon GenomicsOrient BioAll Stocks A–Z →